HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jerzy Jaroszewicz Selected Research

Lipids

1/2022Metabolic syndrome - a new definition and management guidelines: A joint position paper by the Polish Society of Hypertension, Polish Society for the Treatment of Obesity, Polish Lipid Association, Polish Association for Study of Liver, Polish Society of Family Medicine, Polish Society of Lifestyle Medicine, Division of Prevention and Epidemiology Polish Cardiac Society, "Club 30" Polish Cardiac Society, and Division of Metabolic and Bariatric Surgery Society of Polish Surgeons.
9/2017The interplay between Th17 and T-regulatory responses as well as adipokines in the progression of non-alcoholic fatty liver disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jerzy Jaroszewicz Research Topics

Disease

40Infections
04/2024 - 11/2004
16COVID-19
03/2024 - 01/2021
15Chronic Hepatitis C
07/2023 - 11/2005
14Fibrosis (Cirrhosis)
01/2024 - 09/2004
12Chronic Hepatitis B
02/2024 - 09/2004
12Liver Cirrhosis (Hepatic Cirrhosis)
03/2021 - 06/2005
9Liver Diseases (Liver Disease)
07/2023 - 11/2005
7HIV Infections (HIV Infection)
01/2022 - 11/2004
7Hepatitis C
01/2022 - 11/2005
5Coinfection
03/2024 - 01/2012
5Disease Progression
01/2023 - 01/2004
4Hepatocellular Carcinoma (Hepatoma)
03/2024 - 05/2012
4Hepatitis B
02/2024 - 04/2010
4End Stage Liver Disease
05/2021 - 12/2018
4Ulcerative Colitis
04/2008 - 12/2003
3Obesity
01/2024 - 04/2015
3Hepatic Insufficiency
03/2021 - 08/2008
3Inflammation (Inflammations)
09/2017 - 04/2014
3Psoriasis (Pustulosis Palmaris et Plantaris)
04/2015 - 12/2010
3Chronic Hepatitis (Chronic Active Hepatitis)
03/2012 - 09/2004
3Hepatitis
04/2010 - 06/2005
2Renal Insufficiency (Renal Failure)
03/2023 - 01/2005
2Liver Failure
03/2023 - 09/2017
2Genetic Predisposition to Disease (Genetic Predisposition)
01/2023 - 10/2013
2Hepatitis A (Hepatitis, Infectious)
01/2023 - 06/2005
2Neoplasms (Cancer)
09/2022 - 05/2021
2Cardiovascular Diseases (Cardiovascular Disease)
04/2022 - 10/2013
2Hypertension (High Blood Pressure)
01/2022 - 05/2021
2Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2022 - 10/2013
2Alcoholic Liver Diseases (Alcoholic Liver Disease)
01/2021 - 09/2017
2Communicable Diseases (Infectious Diseases)
01/2020 - 09/2018
2Non-alcoholic Fatty Liver Disease
09/2018 - 09/2017
1Post-Acute COVID-19 Syndrome
03/2024
1Epilepsy (Aura)
07/2023
1Pneumonia (Pneumonitis)
03/2023
1Fever (Fevers)
01/2023
1Fatigue
01/2023

Drug/Important Bio-Agent (IBA)

27Antiviral Agents (Antivirals)IBA
04/2024 - 11/2005
12InterferonsIBA
05/2021 - 04/2010
11Biomarkers (Surrogate Marker)IBA
03/2024 - 12/2003
7RNA (Ribonucleic Acid)IBA
01/2023 - 01/2006
7Ribavirin (Virazole)FDA LinkGeneric
07/2021 - 11/2005
7CytokinesIBA
04/2021 - 10/2011
7Hepatitis B Surface Antigens (HBsAg)FDA Link
10/2020 - 04/2010
5EnzymesIBA
12/2017 - 06/2005
4DNA (Deoxyribonucleic Acid)IBA
02/2024 - 04/2010
4C-Reactive ProteinIBA
01/2023 - 04/2008
4Lamivudine (Epivir)FDA Link
04/2011 - 09/2004
4Tissue Inhibitor of Metalloproteinase-1IBA
11/2005 - 12/2003
4Metalloproteases (Metalloproteinases)IBA
11/2005 - 12/2003
4Transforming Growth Factor beta1 (TGF beta 1)IBA
11/2005 - 01/2004
3Proteins (Proteins, Gene)FDA Link
03/2024 - 01/2005
3AntigensIBA
02/2024 - 01/2012
3remdesivirIBA
03/2023 - 01/2021
3Interleukin-6 (Interleukin 6)IBA
01/2023 - 04/2021
3dasabuvirIBA
07/2021 - 09/2019
3ombitasvirIBA
07/2021 - 09/2019
3paritaprevirIBA
07/2021 - 09/2019
3Ritonavir (Norvir)FDA Link
07/2021 - 09/2019
3Interleukin-17 (Interleukin 17)IBA
10/2019 - 06/2015
3Hepatitis B e AntigensIBA
03/2019 - 04/2010
3HepcidinsIBA
12/2017 - 08/2008
3AdipokinesIBA
09/2017 - 10/2013
3InterleukinsIBA
09/2017 - 01/2005
3Keratin-18 (Keratin 18)IBA
01/2017 - 12/2011
3Indicators and Reagents (Reagents)IBA
04/2014 - 12/2011
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2013 - 10/2008
3Interferon-alpha (Interferon Alfa)IBA
10/2011 - 11/2005
2VaccinesIBA
09/2023 - 04/2022
2AutoantibodiesIBA
01/2023 - 09/2017
2fibrin fragment D (D-dimer)IBA
01/2023 - 09/2022
2molnupiravirIBA
12/2022 - 01/2022
2LipidsIBA
01/2022 - 09/2017
2tocilizumab (atlizumab)FDA Link
04/2021 - 01/2021
2Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2020 - 06/2005
2Alanine Transaminase (SGPT)IBA
01/2020 - 06/2005
2Cytidine Triphosphate (CTP)IBA
01/2020 - 12/2018
2ImmunosorbentsIBA
12/2017 - 04/2015
2AdiponectinIBA
04/2015 - 10/2013
2LigandsIBA
05/2012 - 05/2010
2Transaminases (Aminotransferases)IBA
12/2011 - 09/2004
2Peptides (Polypeptides)IBA
10/2011 - 09/2004
2IronIBA
04/2010 - 08/2008
2Transforming Growth Factors (Transforming Growth Factor)IBA
11/2005 - 09/2004
2Interleukin-18 (Interleukin 18)IBA
01/2005 - 11/2004
1Lipocalin-2IBA
03/2024
1ElementsIBA
03/2023
1Particulate MatterIBA
01/2023
1Benzo(a)pyreneIBA
01/2023
1Air Pollutants (Pollutants, Air)IBA
01/2023

Therapy/Procedure

37Therapeutics
01/2024 - 01/2005
3Retreatment
01/2023 - 12/2013
2Aftercare (After-Treatment)
07/2021 - 01/2021
2Renal Dialysis (Hemodialysis)
01/2021 - 01/2005
2Kidney Transplantation
01/2021 - 01/2005
2Duration of Therapy
03/2020 - 06/2017
2Transplantation
01/2016 - 03/2012
1Liver Transplantation
03/2024
1Radiotherapy
03/2023
1Blood Transfusion (Blood Transfusions)
01/2023